CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 837 target
Drug / intervention
MRI or CTdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02422550
NCT02422550N/ARecruitingHigh MomentumUpdated 3mo ago
Long Recruiting

Development and Evaluation of Imaging Acquisition and Analysis Methods for Optimization of MRI and/or CT in Radiation Oncology Simulation, Treatment Planning, and Response Assessment

Memorial Sloan Kettering Cancer Center·observational·Posted Apr 21, 2015·Updated Mar 3, 2026

In Brief

An observational study evaluating MRI or CT for Radiation Therapy. Currently recruiting, targeting 837 participants across 7 sites.

Signals

Enrolling ahead of pace

Detailed Summary

Magnetic resonance imaging (MRI) is currently one of the standard diagnostic imaging methods used to diagnose tumor stage before treatment in the Radiation Oncology Department. It is also used to check responses to radiation after treatment. However, MRI isn't traditionally used in planning for radiation treatment or in checking treated tumor and tissue changes during radiation treatment. The goal is to find out the possible benefits of MRI imaging techniques in these settings of radiation treatment. The research aims are to study the possibility of using devices with new abilities such as the MR-Linac. The MR-Linac combines a radiation treatment machine with a diagnostic MRI scanner. This device will improve the quality of MRI-guided radiation treatment. The MR-Linac has functions that are currently not available in other combined imaging and radiation delivery devices. The MR-Linac does not provide additional imaging capabilities that are not currently available in other imaging devices. Participating in this study would NOT change the current treatment plans, this will allow the investigators to use the MRI methods in research and future patient care.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ARecruiting
2015201620172018201920202021202220232024202520262027
First PostedApr 21, 2015
Enrollment StartApr 9, 2015
Primary CompletionApr 1, 2027
TodayJul 1, 2026
Enrollment to primary: 12.0 yearsPosted 11.2 years agoPrimary completion in 9 months

Interventions

MRI or CTdevice

Participants enrolled on this protocol may undergo multiple MRI or CT examinations periodically over the course of their treatment and follow-up if they are participating in a development project related to tumor response assessment. Volunteers enrolled on this protocol may undergo multiple MRI examinations periodically for studies of reproducibility.